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Active Bacterial Core Surveillance (ABCs) Report 
Emerging Infections Program Network 
Neisseria meningitidis, 2012
ABCs Areas 
California (3 county San Francisco Bay area); 
Colorado (5 county Denver area); Connecticut; 
Georgia; Maryland; Minnesota; New Mexico; New 
York (15 county Rochester and Albany areas); 
Oregon; Tennessee (20 counties) 
 
ABCs Population 
The surveillance areas represent 42,803,061 persons. 
Source: National Center for Health Statistics 
bridged-race vintage 2012 postcensal file 
 
ABCs Case Definition 
Meningococcal disease: isolation of Neisseria 
meningitidis from normally sterile site in a resident of 
a surveillance area in 2012.  
 
ABCs Methodology 
ABCs personnel routinely contacted all microbiology 
laboratories serving acute care hospitals in their area to 
identify cases. Standardized case report forms that 
include information on demographic characteristics, 
clinical syndrome, and outcome of illness were 
completed for each identified case.  Serogrouping of 
meningococcal isolates was done at CDC and state 
laboratories. Regular laboratory audits assessed 
completeness of active surveillance and detected 
additional cases.  
All rates of  meningococcal disease were calculated 
using population estimates for 2012. For national 
estimates of cases, race- and age-specific rates of 
disease were applied from the aggregate surveillance 
area to the age and racial distribution of the 2012 U.S. 
population for 49 states (excluding Oregon due to an 
outbreak of serogroup B disease). The Oregon reported 
cases were then added to obtain the national estimates. 
Cases with missing data, excluding ethnicity, were 
multiply imputed using the sequential regression 
imputation method.¶ 
Reported ABCs Profiles 
Race             No.    (Rate*) 
White 62 (0.19) 
Black 11 (0.14) 
Other 7 (0.21) 
Total 80 (0.19) 
* Cases per 100,000 population for ABCs areas 
 Cases Deaths 
Syndrome      No.  (%*) No.  (Rate†) 
Meningitis 37   (46.3) 6   (16.2) 
Bacteremia without focus 22   (27.5) 2   (9.5) 
* Percent of cases                                                                                                                           
† Deaths per 100 cases with known outcome 
          
¶ Surveillance Note 
Missing race (n=14) data were multiply imputed using sequential regression 
imputation methods.  
                         Serogroups  
Age B C Y Other‡ 
 (years)    No.  (Rate*)  No.  (Rate*)   No. (Rate*)  No. (Rate*) 
< 1 6 (1.24) 0 (0.00) 1 (0.21) 2 (0.41) 
1  2 (0.41) 0 (0.00) 0 (0.00) 0 (0.00) 
2-4 2 (0.13) 1 (0.07) 0 (0.00) 0 (0.00) 
5-17 1 (0.02) 0 (0.00) 3 (0.05) 0 (0.00) 
18-34 9 (0.10) 6 (0.07) 2 (0.02) 0 (0.00) 
35-49 1 (0.01) 2 (0.03) 3 (0.04) 2 (0.03) 
50-64   1 (0.01) 1 (0.01) 3 (0.04) 1 (0.01) 
≥ 65 1 (0.02) 0 (0.00) 7 (0.14) 0 (0.00) 
Total † 23 (0.06) 10 (0.03) 19 (0.05) 5 (0.01) 
 
Unknown serogroup (n=2) distributed amongst known 
*Cases per 100,000 population for ABCs areas excluding Oregon 
† All rates exclude Oregon.  Rates including Oregon are    serogroup B 0.08, 
serogroup C 0.04, serogroup Y 0.06, and serogroup Other 0.01 cases per 
100,000 population for ABCs areas 
‡ Other includes serogroup W-135 and non-groupables 
 
 
Rates of Meningococcal Disease in Adolescents 
and Young Adults† 
 
Overall 
Serogroups 
C/Y/W-135 
Serogroups 
Age (years)        No.  (Rate*)       No.  (Rate*) 
11-17 4 (0.11) 3 (0.08) 
18-22 5   (0.18)  2 (0.07)  
 
* Cases per 100,000 population for ABCs areas excluding Oregon 
† All rates exclude Oregon.  Rates including Oregon are, for 11-17 year 
olds, overall serogroups 0.15 and serogroup C/Y/W-135 0.13; for 18-22 
year olds, overall serogroups 0.27 and serogroup C/Y/W-135 0.10 cases per 
100,000 population for ABCs areas 
 
National Estimates for Disease ¥ 
 Cases:         480    (0.15/100,000)    
 Deaths:         75    (0.02/100,000) 
 
¥ In 2012, 551 cases of meningococcal disease (probable and confirmed) 
were reported to the National Notifiable Disease Surveillance System 
(incidence 0.18/100,000 population) 
 
Healthy People 2020 Update 
Objective: Reduce the incidence of meningococcal 
disease to 0.3 per 100,000 population. 
2020 Objective 2012 Rate*  
0.3/100,000     0.15/100,000  
* Cases per 100,000 U.S. population  
 
For more information, visit our web site: 
 http://www.cdc.gov/abcs  
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